文献速递消化、代谢与肾脏急症

计入观察性留院增长后评估Medicare医院再入院减少计划

Accounting for the Growth of Observation Stays in the Assessment of Medicare's Hospital Readmissions Reduction Program.
PubMed 文献 · JAMA Netw Open · 2022-11-01
一句话结论计入观察性留院后,HRRP相关再入院率绝对降幅缩小一半以上,目标疾病降幅从-1.48个百分点变为-0.66个百分点。

该回顾性队列研究纳入2009年1月1日至2015年12月31日Medicare按服务收费受益人的20%住院和观察性留院样本,用双重差分法比较HRRP宣布及惩罚实施前后目标疾病(心力衰竭、急性心肌梗死、肺炎)与非目标疾病的30天再入院变化。仅计住院时,目标疾病再入院率绝对降幅为-1.48个百分点(95%CI,-1.65至-1.31),非目标疾病为-1.13个百分点(95%CI,-1.30至-0.96),差异变化为-0.35个百分点(95%CI,-0.59至-0.11)。计入观察性留院后,目标疾病降幅减半以上至-0.66个百分点(95%CI,-0.83至-0.49),非目标疾病为-0.76个百分点(95%CI,-0.92至-0.59),差异变化为0.10个百分点(95%CI,-0.14至0.33),无统计学显著性。

要点

  • 目标疾病观察性留院占指数住院比例从2.3%升至4.4%(相对增加91.3%),非目标疾病从14.1%升至21.3%(相对增加51.1%)。
  • 仅计住院入院时,目标疾病再入院率绝对降幅为-1.48个百分点(95%CI,-1.65至-1.31),非目标疾病为-1.13个百分点(95%CI,-1.30至-0.96)。
  • 计入观察性留院后,目标疾病再入院率绝对降幅减半以上至-0.66个百分点(95%CI,-0.83至-0.49)。
  • HRRP宣布后再入院率显著下降,但在惩罚实施时已回到基线,无论是否计入观察性留院、无论目标还是非目标疾病均如此。
  • 目标疾病与非目标疾病再入院率差异变化在计入观察性留院后为0.10个百分点(95%CI,-0.14至0.33),无统计学显著性。

适用人群与场景

  • 2009年1月1日至2015年12月31日Medicare按服务收费受益人20%的住院入院和观察性留院样本。

研究设计与关键结果

  • 研究类型:回顾性队列研究;样本量:8 944 295例住院;人群:Medicare按服务收费受益人,平均(SD)年龄78.7(8.2)岁,女性58.6%,亚裔1.3%,黑人10.0%,西班牙裔2.0%,北美原住民0.5%,白人85.0%,其他或未知1.2%。
  • 干预与对照:比较HRRP宣布及对目标疾病(心力衰竭、急性心肌梗死、肺炎)实施惩罚前后目标疾病与非目标疾病的30天再入院变化,采用双重差分分析,分别在不计入和计入观察性留院两种情景下评估。
  • 主要终点结果:仅计住院时,目标疾病再入院率绝对降幅为-1.48个百分点(95%CI,-1.65至-1.31),非目标疾病为-1.13个百分点(95%CI,-1.30至-0.96),差异变化为-0.35个百分点(95%CI,-0.59至-0.11)。
  • 计入观察性留院后,目标疾病再入院率绝对降幅为-0.66个百分点(95%CI,-0.83至-0.49),非目标疾病为-0.76个百分点(95%CI,-0.92至-0.59),差异变化为0.10个百分点(95%CI,-0.14至0.33),无统计学显著性。
  • 观察性留院变化:目标疾病观察性留院占指数住院比例从2.3%升至4.4%(相对增加91.3%),非目标疾病从14.1%升至21.3%(相对增加51.1%)。
  • 再入院率在HRRP宣布后显著下降,但在惩罚实施时已回到基线,无论是否计入观察性留院、无论目标还是非目标疾病均如此。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与HRRP实施相关的再入院率下降比最初报告的更小。
  • 作者认为,目标疾病再入院率下降的一半以上似乎可归因于将住院入院重新归类为观察性留院。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Decreases in 30-day readmissions following the implementation of the Medicare Hospital Readmissions Reduction Program (HRRP) have occurred against the backdrop of increasing hospital observation stay use, yet observation stays are not captured in readmission measures.

OBJECTIVE: To examine whether the HRRP was associated with decreases in 30-day readmissions after accounting for observation stays.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included a 20% sample of inpatient admissions and observation stays among Medicare fee-for-service beneficiaries from January 1, 2009, to December 31, 2015. Data analysis was performed from November 2021 to June 2022. A differences-in-differences analysis assessed changes in 30-day readmissions after the announcement of the HRRP and implementation of penalties for target conditions (heart failure, acute myocardial infarction, and pneumonia) vs nontarget conditions under scenarios that excluded and included observation stays.

MAIN OUTCOMES AND MEASURES: Thirty-day inpatient admissions and observation stays.

RESULTS: The study included 8 944 295 hospitalizations (mean [SD] age, 78.7 [8.2] years; 58.6% were female; 1.3% Asian; 10.0% Black; 2.0% Hispanic; 0.5% North American Native; 85.0% White; and 1.2% other or unknown). Observation stays increased from 2.3% to 4.4% (91.3% relative increase) of index hospitalizations among target conditions and 14.1% to 21.3% (51.1% relative increase) of index hospitalizations for nontarget conditions. Readmission rates decreased significantly after the announcement of the HRRP and returned to baseline by the time penalties were implemented for both target and nontarget conditions regardless of whether observation stays were included. When only inpatient hospitalizations were counted, decreasing readmissions accrued into a -1.48 percentage point (95% CI, -1.65 to -1.31 percentage points) absolute reduction in readmission rates by the postpenalty period for target conditions and -1.13 percentage point (95% CI, -1.30 to -0.96 percentage points) absolute reduction in readmission rates by the postpenalty period for nontarget conditions. This reduction corresponded to a statistically significant differential change of -0.35 percentage points (95% CI, -0.59 to -0.11 percentage points). Accounting for observation stays more than halved the absolute decrease in readmission rates for target conditions (-0.66 percentage points; 95% CI, -0.83 to -0.49 percentage points). Nontarget conditions showed an overall greater decrease during the same period (-0.76 percentage points; 95% CI, -0.92 to -0.59 percentage points), corresponding to a differential change in readmission rates of 0.10 percentage points (95% CI, -0.14 to 0.33 percentage points) that was not statistically significant.

CONCLUSIONS AND RELEVANCE: The findings of this study suggest that the reduction of readmissions associated with the implementation of the HRRP was smaller than originally reported. More than half of the decrease in readmissions for target conditions appears to be attributable to the reclassification of inpatient admission to observation stays.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Sabbatini AK, Joynt-Maddox KE, Liao JM, et al. Accounting for the Growth of Observation Stays in the Assessment of Medicare's Hospital Readmissions Reduction Program. JAMA Netw Open. 2022. PMID: 36394872. doi:10.1001/jamanetworkopen.2022.42587

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。